1.Meta-analysis of 342 Female Pseudohermaphroditism
Quanrong LI ; Bei UN ; Xiling YI ; Shuice LIU ; Shengtan WANG ; Shulan ZHANG
Journal of China Medical University 2010;(1):64-66,70
Objective To summarize the clinical characteristics of female pseudohermaphroditism (FPH) in the publication from 1994 to 2009 and the cases diagnosed and treated in our hospital from 2000.Methods We employed Chinese and English name of female pseudohermaphroditism as a key word separately to retrieve published articles of FPH during 1994 to 2009.A meta-analysis was performed together with the ten cases in our hospital.Results Among 342 cases involved in this study,only twenty-seven children were diagnosed immediately after birth and the other 315 cases at the age of 1 month to 59 years with median age of 29.54 years.The etiological factors were mostly congenital adrenal hyperplasia (70.47%).Clinical manifestations were advanced bone age (95.52%),clitoromegaly (84.14%) and early virilization (77.24%).The treatment mainly included drug and operation.Early diagnosis and available therapy were very important for the prognosis.Conclusion FPH is not rare,so we should improve our knowledge for its early diagnosis,good intervention and final better prognosis.
2.Recent advance in patent foramen ovale closure for treatment of migraine
Jiayu DIAO ; Xiling SHOU ; Yi WANG ; Xiaowei YAO
Chinese Journal of Neuromedicine 2021;20(9):967-970
Migraine is a common disease that can cause disability, whose pathogeneses included traditional theory of vascular origin, cortical diffusion inhibition and trigeminal neurovascular reflex. Recent studies have found that there is a close relationship between patent foramen ovale (PFO) and migraine. With the development of cardiac catheterization technology, PFO closure has been used in treatment of migraine. A number of clinical studies have shown that PFO closure improves the symptoms of patients with migraine, especially the onset of migraine with aura. This article will review the research progress of PFO closure in the treatment of migraine.
3.Rosmarinic acid inhibits high glucose-induced cardiomyocyte hypertrophy by activating Parkin-mediated mitophagy.
Jiayu DIAO ; Hongmou ZHAO ; Yujie NING ; Wenqi HAN ; Yi WANG ; Gong CHENG ; Xiling SHOU ; Hongjun YOU
Journal of Southern Medical University 2020;40(11):1628-1633
OBJECTIVE:
To evaluate the effect of rosmarinic acid (RA) on mitophagy and hypertrophy of cardiomyocytes exposed to high glucose (HG).
METHODS:
Rat cardiomyocytes (H9c2) exposed to HG (25 mmol/L) were treated with 50 μmol/L RA or with both RA treatment and Parkin siRNA transfection, with the cells cultured in normal glucose (5.5 mmol/L) and HG as the controls. The expressions of PINK1, Parkin and LC3II/LC3I in the cells were detected by Western blotting. The formation of mitochondrial autophagosomes was observed by transmission electron microscope. Flow cytometry was employed to detect the level of reactive oxygen species (ROS) and apoptotic rate of the cells. The activities of respiratory chain complex enzymes were measured by spectrophotometry. Fluorescence enzyme labeling and
RESULTS:
RA treatment significantly increased the expression levels of PINK1, Parkin and LC3-II/I (
CONCLUSIONS
RA can protect rat cardiomyocytes against oxidative stress injury and cardiomyocyte hypertrophy induced by HG by activating Parkin-mediated mitophagy.
Animals
;
Cinnamates
;
Depsides
;
Glucose
;
Hypertrophy
;
Mitophagy
;
Myocytes, Cardiac
;
Protein Kinases
;
Rats
;
Reactive Oxygen Species
;
Ubiquitin-Protein Ligases/genetics*